XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 25.33

-1.9%

Dec 17 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Cacaito who wrote (15885)	7/16/2002 6:45:42 PM
From: aknahow	Read Replies (1) of 17367

Sad, sad, sad! While I recognize that DNA screwed up by not limiting the number of subjects treated with the Xoma produced Xanelim you have no idea about what happened with the request for a complete response. It means a delay and to say BGEN is on track is not correct. It has now been delayed and how long depends on how quick BGEN provides the complete response and how long it takes the FDA to reply to BGEN. Fl Mist is not being subject to new trials. It simply got another request for a complete response after providing a complete response to the first request. BGEN rushed to file, with trials based not on weight but one dose fits all. They did not have 1.500 subjects but only 1,350. The FDA wondered about both the efficacy and duration numbers provided by BGEN. Nice to know that you accept anything BGEN says without question. BGEN = clone of IMCL/ELN!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next